The viral Epidemiology Branch has used a variety of approaches to define the nature and magnitude of HIV-1 associated malignancies, including analyses of population-based cancer registries, death certificates, prospective cohorts, and laboratory studies. A major focus in the past year has been on the nature and etiology of Kaposi's sarcoma, which was recently associated with a newly discovered herpesvirus, HHV-8. In a collaboration with the Laboratory of Pathology, NCI, HHV-8 was localized by microdissection to spindle cell areas of Kaposi's sarcoma tissue sections whereas it was absent from stromal areas. VEB researchers have extended their previous finding of monoclonality of this tumor by determining that multiple lesions share the same clonal origin, further establishing Kaposi's sarcoma as a true malignant neoplasm. In studies of HIV-infected hemophilia patients, non-Hodgkin's lymphoma incidence increased exponentially with duration of HIV infection, reaching 7% (95% confidence limits, 1%-12%) per year 15 or more years after HIV-1 seroconversion. The incidence of malignancies other than Kaposi's sarcoma and non-Hodgkin's lymphoma was not significantly increased overall, although Hodgkin's disease was increased 5.6-fold (95% confidence limits, 1.1-16). HIV-viral load was not associated with lymphoma or cancer risk. Cancer surveillance data from the pre-AIDS era were analyzed for cancer risks associated with single marital status (a surrogate for homosexuality in men); except for anal cancers, no increases were found. Recent analyses of the Multistate AIDS-Cancer Match Registry have elucidated the impact of AIDS on the epidemiology of central nervous system and systemic non-Hodgkin's lymphoma and on Kaposi's sarcoma. No increase was detectable in risk of nasopharyngeal carcinoma, an EBV-associated tumor. Current efforts have linked 90,000 AIDS cases with cancer registry data, and an expanded match is planned for 1997 to better explore rare tumor types and cancer in small population subgroups.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CP005781-02
Application #
2456723
Study Section
Special Emphasis Panel (VEB)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Biggar, R J; Frisch, M; Goedert, J J (2000) Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA 284:205-9
Zhang, Y J; Deng, J H; Rabkin, C et al. (2000) Hot-spot variations of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen and application in genotyping by PCR-RFLP. J Gen Virol 81:2049-58
Engels, E A; Frisch, M; Biggar, R J et al. (2000) AIDS-Related opportunistic illness and potent antiretroviral therapy. JAMA 283:2653-4
Rabkin, C S (2000) The need for investigations of prophylactic regimens to prevent AIDS-associated non-Hodgkin's lymphoma. Clin Infect Dis 30:762-3
Frisch, M; Biggar, R J; Goedert, J J (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500-10
Biggar, RJ; Frisch, M (2000) Estimating the Risk of Cancer in Children With AIDS. JAMA 284:2593-2594
Zong, J C; Ciufo, D M; Alcendor, D J et al. (1999) High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 73:4156-70
Rabkin, C S (1999) Epidemiology of B-cell lymphomas. Curr Top Microbiol Immunol 246:235-9;discussion 240
Rabkin, C S; Sei, S (1999) Susceptibility genes for AIDS and AIDS-related lymphoma. Curr Top Microbiol Immunol 246:111-4;discussion 115
Rabkin, C S; Testa, M A; Huang, J et al. (1999) Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. J Acquir Immune Defic Syndr 21 Suppl 1:S31-3

Showing the most recent 10 out of 13 publications